Hamilton Wealth’s Novo Nordisk NVO Stock Holding History

Hamilton Wealth’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-10,720	Closed	-$545K	–	128
2025 Q4	$545K	Buy	+10,720	New	+$548K	0.1%	71
2025 Q3	–	Sell	-52,998	Closed	-$3.66M	–	128
2025 Q2	$3.66M	Buy	52,998 +49,565	+1,444%	+$3.37M	0.82%	33
2025 Q1	$238K	Sell	3,433 -95,194	-97%	-$7.86M	0.06%	91
2024 Q4	$8.48M	Buy	98,627 +79,470	+415%	+$8.59M	2.06%	14
2024 Q3	$2.28M	Sell	19,157 -21,126	-52%	-$2.82M	0.56%	40
2024 Q2	$5.75M	Sell	40,283 -23,573	-37%	-$3.12M	1.55%	23
2024 Q1	$8.2M	Buy	63,856 +32,382	+103%	+$3.85M	2.56%	12
2023 Q4	$3.26M	Buy	31,474 +29,148	+1,253%	+$2.88M	1.02%	30
2023 Q3	$212K	Buy	+2,326	New	+$205K	0.08%	86

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Hamilton Wealth's NVO Position: Q1 2026 in Review

Hamilton Wealth sold out of Novo Nordisk (NVO) in Q1 2026, closing a stake of 10,720 shares — an estimated $545K sold.

Hamilton Wealth first reported a position in NVO in Q3 2023 and held it in 9 quarters. The position peaked at $8.48M in Q4 2024. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Hamilton Wealth reported no remaining Novo Nordisk position as of Q1 2026 after selling out during the quarter.
Hamilton Wealth sold 10,720 Novo Nordisk shares in Q1 2026, an estimated $545K.
Hamilton Wealth first reported a position in Novo Nordisk in Q3 2023 and held it in 9 quarters.
Hamilton Wealth's Novo Nordisk position peaked at $8.48M in Q4 2024.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Hamilton Wealth's 13F filing for Q1 2026, filed 18 May 2026.